全文获取类型
收费全文 | 21510篇 |
免费 | 1665篇 |
国内免费 | 1594篇 |
专业分类
24769篇 |
出版年
2024年 | 56篇 |
2023年 | 248篇 |
2022年 | 664篇 |
2021年 | 1158篇 |
2020年 | 766篇 |
2019年 | 945篇 |
2018年 | 910篇 |
2017年 | 678篇 |
2016年 | 947篇 |
2015年 | 1303篇 |
2014年 | 1591篇 |
2013年 | 1725篇 |
2012年 | 1916篇 |
2011年 | 1786篇 |
2010年 | 1100篇 |
2009年 | 994篇 |
2008年 | 1141篇 |
2007年 | 1010篇 |
2006年 | 863篇 |
2005年 | 742篇 |
2004年 | 569篇 |
2003年 | 546篇 |
2002年 | 446篇 |
2001年 | 324篇 |
2000年 | 328篇 |
1999年 | 325篇 |
1998年 | 190篇 |
1997年 | 170篇 |
1996年 | 181篇 |
1995年 | 176篇 |
1994年 | 158篇 |
1993年 | 116篇 |
1992年 | 159篇 |
1991年 | 113篇 |
1990年 | 110篇 |
1989年 | 77篇 |
1988年 | 54篇 |
1987年 | 46篇 |
1986年 | 35篇 |
1985年 | 35篇 |
1984年 | 17篇 |
1983年 | 15篇 |
1982年 | 18篇 |
1981年 | 7篇 |
1980年 | 4篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1975年 | 2篇 |
1966年 | 1篇 |
1950年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
851.
852.
Jian-kang Jiang Xiuli Huang Khalida Shamim Paresma R. Patel Arthur Lee Amy Q. Wang Kimloan Nguyen Gregory Tawa Gregory D. Cuny Paul B. Yu Wei Zheng Xin Xu Philip Sanderson Wenwei Huang 《Bioorganic & medicinal chemistry letters》2018,28(20):3356-3362
The pyrazolo[1,5-a]pyrimidine LDN-193189 is a potent inhibitor of activin receptor-like kinase 2 (ALK2) but is nonselective for highly homologous ALK3 and shows only modest kinome selectivity. Herein, we describe the discovery of a novel series of potent and selective ALK2 inhibitors by replacing the quinolinyl with a 4-(sulfamoyl)naphthyl, yielding ALK2 inhibitors that exhibit not only excellent discrimination versus ALK3 but also high kinome selectivity. In addition, the optimized compound 23 demonstrates good ADME and in vivo pharmacokinetic properties. 相似文献
853.
Yuan Zhou Shasha Zhang Hongwu He Wen Jiang Leifeng Hou Dan Xie Meng Cai Hao Peng Lingling Feng 《Bioorganic & medicinal chemistry》2018,26(1):84-95
In order to obtain PDHc-E1 inhibitors with high selectivity and efficacy, four series (7, 12, 15, and 19) of 35 novel 4-aminopyrimidine derivatives were rationally designed and synthesized based on the binding site of ThDP in E. coli PDHc-E1. 12, 15, and 19 were confirmed to be potent inhibitors against E. coli PDHc-E1. Selected compounds 12g, 12i, 15f, and 19a showed negligible inhibition against porcine PDHc-E1. To understand their selectivity, the interaction of inhibitor and E. coli PDHc-E1 or porcine PDHc-E1 was studied by molecular docking. The newly introduced acylhydrazone and N-phenylbenzamide moieties could form stronger interaction by hydrogen bond at the active site of E. coli PDHc-E1 compared with that of porcine PDHc-E1. A part of title compounds as potent PDHc-E1 inhibitors also exhibited notable antibacterial activity. In particular, 12e, 12f, 12g, 12o, and 19a exhibited 72–92% inhibition against Xanthomonas oryzae pv. Oryzae and Ralstonia solanacearum at 100?μg/mL, which was better than thiodiazole-copper (34 and 29%, respectively) and bismerthiazol (56 and 55%, respectively). The results proved that we could obtain effective bactericidal compounds as highly selective PDHc inhibitors by rational molecular design utilizing the binding model of active site of E. coli PDHc-E1. 相似文献
854.
Ting Shao Peiying Song Qingbin Kong Hui Hua Ting Luo Yangfu Jiang 《Journal of cellular and molecular medicine》2018,22(1):589-599
The natural agent rhein is an ananthraquinone derivative of rhubarb, which has anticancer effects. To determine the mechanisms underlying the anticancer effects of rhein, we detected the effect of rhein on several oncoproteins. Here, we show that rhein induces β‐catenin degradation in both hepatoma cell HepG2 and cervical cancer cell Hela. Treatment of HepG2 and Hela cells with rhein shortens the half‐life of β‐catenin. The proteasome inhibitor MG132 blunts the downregulation of β‐catenin by rhein. The induction of β‐catenin degradation by rhein is dependent on GSK3 but independent of Akt. Treatment of HepG2 and Hela cells with GSK3 inhibitor or GSK3β knockdown abrogates the effect of rhein on β‐catenin. GSK3β knockdown compromises the inhibition of HepG2 and Hela cell growth by rhein. Furthermore, rhein dose not downregulate β‐catenin mutant that is deficient of phosphorylation at multiple residues including Ser33, Ser37, Thr41 and Ser45. Moreover, rhein induces cell cycle arrest at S phase in both HepG2 and Hela cells. Intraperitoneal administration of rhein suppresses tumour cells proliferation and tumour growth in HepG2 xenografts model. Finally, the levels of β‐catenin are reduced in rhein‐treated tumours. These data demonstrate that rhein can induce β‐catenin degradation and inhibit tumour growth. 相似文献
855.
856.
Chong Shen Tongmeng Jiang Bo Zhu Yiguan Le Jianwei Liu Zainen Qin Haimin Chen Gang Zhong Li Zheng Jinmin Zhao Xingdong Zhang 《Journal of biological engineering》2018,12(1):26
In vitro expansion of mesenchymal stem cells (MSCs) has been implicated in loss of multipotency, leading to impaired chondrogenic potential and an eventual therapeutic effect, as reported in our previous study. However, the precise regulatory mechanism is still unclear. Here, we demonstrate that endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) were involved in transformation of MSCs induced by in vitro culture based on the comparative profiling of in vitro cultured bone marrow MSCs at passage 3 (P3 BMSCs) vs. fresh P0 BMSCs by microarray analysis. Indeed, RT-PCR and Western blot analysis showed significantly lower expression levels of three key UPR-related molecules, ATF4, ATF6 and XBP1, in P3 BMSCs than P0 BMSCs. Further, we found that UPR suppression by 4-phenylbutyrate (4-PBA) reduced the chondrogenic potential of P0 BMSCs and further cartilage regeneration. Conversely, UPR induction by tunicamycin (TM) enhanced the chondrogenic differentiation of P3 BMSCs and the therapeutic effect on cartilage repair. Thus, the decline in the chondrogenic potential of stem cells after in vitro culture and expansion may be due to changes in ER stress and the UPR pathway. 相似文献
857.
Hongchao Lv Yongshuai Jiang Jin Li Mingming Zhang Zhenwei Shang Jiajia Zheng Xin Wu Panpan Liu Ruijie Zhang Huimin Yu 《Molecular biology reports》2014,41(3):1299-1310
The aim of this study was to assess the association of polymorphisms in the promoter region of the IL-10 gene with the risk of inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC). Fifteen studies (3,693 cases and 4,574 controls) were included in a meta-analysis of association between IL-10 ?1082G/A, ?819C/T and ?592C/A polymorphisms, and IBD, CD and UC using allele contrast and the recessive, dominant, and additive models. Hardy–Weinberg equilibrium was confirmed for each study. Heterogeneity and study quality were investigated using stratification analyses and sensitivity analyses. Polymorphism ?1082G/A showed significant association with CD, with odds ratios (ORs) for the GG + GA genotype and GG versus AA genotype of 1.278 (1.004–1.627) and 1.238 (1.027–1.492) in all subjects. Significant associations were found in the Caucasian subgroup using the allele contrast, dominant, and additive models. C-allele carriers of the ?819C/T polymorphism were at increased risk of IBD (OR 1.093, 95 % CI 1.004–1.190). Association with the ?819C/T polymorphism was also found in Caucasians with CD (C vs. T: OR 1.104, 95 % CI 1.010–1.206; CC + CT vs. TT: OR 1.328, 95 % CI 1.006–1.754; CC vs. TT: OR 1.339, 95 % CI 1.008–1.778), and with UC (CC vs. CT + TT: OR 1.188, 95 % CI 1.019–1.385). No significant association was found between the ?592C/A polymorphism and IBD, CD or UC. In conclusion, the meta-analysis demonstrated clear association between the IL-10 polymorphisms ?1082G/A and ?819C/T and the risk of IBD. 相似文献
858.
859.
860.
目的分析23例重症水痘临床特点。方法收集23例重症水痘患者的临床资料,分析其临床特征。结果重症水痘患者可出现心、肺、肝、脑、肾、胃肠道等多脏器受累表现,这些患者或是机体内存在免疫力低下的各种因素,或是因对疾患缺乏一定认知,从而存在延误就诊或是诊疗不规则,因此出现重症表现。结论提高认知、早期诊断、规范治疗对减低重症水痘发病率及改善预后有重要意义。 相似文献